Clinical Trial Update: A Study to Evaluate the Clinical Efficacy and Safety of Tobradex® ST Compared to Azasite® in the Treatment of Subjects With Moderate to Severe Chronic Blepharitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the clinical efficacy and safety of Tobradex ST versus Azasite for treatment of moderate to severe chronic blepharitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Blepharitis

Drugs mentioned

• AZASITE (AZITHROMYCIN MONOHYDRATE)
• TOBRADEX ST (TOBRAMYCIN / DEXAMETHASONE)

Snippet

Sponsor: Alcon Research | Conditions: Blepharitis | Phase 3 | Status: COMPLETED